Improving Compliance With Medical Testing Guidelines
- Conditions
- Colon CancerBreast CancerCervical CancerLung CancerProstate Cancer
- Registration Number
- NCT02430948
- Lead Sponsor
- Beth Israel Medical Center
- Brief Summary
The study hypothesis is that clearer visual presentation of guideline recommendations and educational outreach, or academic detailing, can improve guideline compliance. However, it will investigate other aspects of screening-related decision-making, such as provider and patient beliefs about screening, provider-patient communication and patient's willingness to forgo expected testing. The research question is whether educational interventions can decrease non-compliance with screening guidelines for 5 common cancers.
- Detailed Description
This study is a cluster randomized trial that compares the immediate post-encounter impressions of 12 physicians and 18 of their patients about the discussion of screening for breast, cervical, colorectal, lung and prostate cancer as well as their beliefs about screening efficacy and patient reports of the screening experience. The interventions are educational materials and academic detailing (educational outreach) for providers. The investigators are particularly interested in contrasting the patient and provider recollections, the differential impact on underuse and overuse compliance and whether patient behaviors are consistent with their stated screening plans.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 218
- Patients: healthy men and women ages 30-89 seeing their primary care provider for routine visit
- Providers: non-pediatric primary care physicians from Mount Sinai Beth Israel or St. Luke's-Roosevelt associated practices
- Patient life expectancy of less than 1 year in primary care provider's judgment
- Inability to read and understand English
- Transgender status
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- FACTORIAL
- Primary Outcome Measures
Name Time Method Effect of educational intervention on providers' recommendations 12 months Incidence of guidance compliance
- Secondary Outcome Measures
Name Time Method Patient compliance 12 months measured by self- report in surveys to be determined
Patients' belief in the value of screening 12 months measured by survey to be determined
Trial Locations
- Locations (2)
Mount Sinai Beth Israel
🇺🇸New York, New York, United States
St. Luke's-Roosevelt
🇺🇸New York, New York, United States
Mount Sinai Beth Israel🇺🇸New York, New York, United States